Close Menu

coronary artery disease

The data, presented at the American College of Cardiology meeting, showed that doctors referred only 4 percent of women with low Corus CAD scores for further cardiac evaluation.

A meta-analysis on tens of thousands of individuals suggests cholesterol-lowering statin drugs may be particularly beneficial for those genetically prone to heart disease.

In an SEC document, the company called current market conditions for an IPO unattractive. 

CardioDx Raises $35M

The financing will go toward further commercialization of its Corus CAD test, as well as other genomics tests for coronary artery disease. 

NEW YORK (GenomeWeb) – Results of a single-center retrospective study focusing on a predominately African-American patient population have added to mounting evidence that Corus CAD, CardioDx's gene expression-based coronary artery disease rule-out test, can help clinicians avoid unnecessary refer

NEW YORK (GenomeWeb) – Cardiovascular molecular diagnostics company CardioDx has raised $21 million toward a targeted goal of $25 million, it disclosed in a regulatory document filed on Wednesday.

NEW YORK (GenomeWeb) – CardioDx today announced that Aetna has established a clinical policy for the Corus CAD gene expression test for coronary artery disease.

NEW YORK (GenomeWeb) – CardioDx's 2013 revenues increased more than three-fold year over year, the company said in a regulatory document on Monday.

NEW YORK (GenomeWeb News) – Medison will make available CardioDx's Corus CAD diagnostic test for obstructive coronary artery disease in Israel as part of an agreement announced today.

A prospective study by a group of several primary care clinics and funded by CardioDx has found that CardioDx's coronary artery disease rule-out test, Corus CAD, significantly affected physician decision making in the primary care setting, changing doctors' treatment strategy for

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.